# Customer and market, phase 5, round 1

## Analysis

Bottom line: four published sources show the buyer's side of both uncertainties, and on the latest readings both lean toward end A. Research was confined to confirming addresses and readings; the EUR-Lex page returned empty on fetch, so its reading is carried from phase 2.

**Id:** CM1. **Uncertainty:** U1. **Name:** Section 232 medical proclamation. **What is measured:** whether a presidential proclamation under Section 232 adjusts imports of medical equipment, and whether it names finished MR (magnetic resonance) systems or components (N08, N10, N18, N36). **Source name:** Federal Register API, presidential documents. **Source link:** https://www.federalregister.gov/api/v1/documents.json?conditions[term]=%22Adjusting+Imports%22+medical&conditions[type][]=PRESDOCU. **Cadence:** daily. **Mode:** live. **Settles toward A when:** the proclamation covers finished scanners only, or the investigation closes without action. **Settles toward B when:** the proclamation or its annex lists magnet-grade wire, cryocoolers or control logic, or imposes quotas that hold parts at the border. **False signal:** a proclamation on a neighbouring sector that mentions medical supplies in passing; the query returns these and they move nothing here. **Last read:** three proclamations on 11 October 2026 (vehicles, semiconductors, pharmaceuticals, latest 9 April 2026); none concerns medical devices. **Leans toward:** a.

**Id:** CM2. **Uncertainty:** U1. **Name:** European origin rule on medical tenders. **What is measured:** the status of Regulation (EU) 2025/1197, which bars Chinese-origin medical devices from tenders at or above 5 million euros, and any widening, counter-measure or withdrawal (N17, N28, N36). **Source name:** EUR-Lex. **Source link:** https://eur-lex.europa.eu/eli/reg_impl/2025/1197/oj/eng. **Cadence:** on amendment, read quarterly. **Mode:** manual. **Settles toward A when:** the measure stays at its threshold or is withdrawn after a settlement; nothing stops. **Settles toward B when:** the threshold is removed, the measure extends to components, or a Chinese counter-rule bars foreign-built MR systems from Chinese hospitals. **False signal:** a European preference clause in the procurement directives; it scores origin rather than barring it, so it stays a cost. **Last read:** in force from 30 June 2025 with no expiry on its face (carried from phase 2; the page returned empty on 11 October 2026). **Leans toward:** a.

**Id:** CM3. **Uncertainty:** U2. **Name:** Sealed magnets in new United States clearances. **What is measured:** 510(k) clearances in product code LNH (MR diagnostic systems), read for sealed designs and the first 3 tesla sealed clearance (N05, N19, N34, N36). **Source name:** openFDA device 510(k) endpoint. **Source link:** https://api.fda.gov/device/510k.json?search=product_code:LNH&sort=decision_date:desc&limit=10. **Cadence:** weekly. **Mode:** live for the list; a person reads each summary for the sealed attribute. **Settles toward A when:** no 3 tesla sealed clearance appears by 2028 and sealed designs stay a minority. **Settles toward B when:** a 3 tesla sealed magnet clears and sealed designs take most new clearances for two years running. **False signal:** a run of low-field and portable clearances; they use little helium but do not replace the fleet tenders buy, which is the Contrarian's fifth future, not U2 end B. **Last read:** 1,107 clearances on 11 October 2026; the ten most recent (6 April to 16 September 2026) are mostly low-field, portable or software, and none names a sealed 3 tesla magnet. The OEM's 1.5 tesla sealed option cleared 5 February 2026 (phase 3). **Leans toward:** a.

**Id:** CM4. **Uncertainty:** U2. **Name:** MR on the regulator's shortage list. **What is measured:** whether any MR product code or helium-dependent imaging device appears on the FDA device shortages list under Section 506J, which is what a procurement team sees before accepting a longer lead time (N01, N19, N34, N36). **Source name:** FDA medical device shortages list. **Source link:** https://www.fda.gov/medical-devices/medical-device-supply-chain-and-shortages/medical-device-shortages-list. **Cadence:** as notified; read monthly. **Mode:** manual. **Settles toward A when:** an MR code is listed with helium supply as the reason. **Settles toward B when:** no imaging code is listed through 2028 while Gulf transit normalises. **False signal:** a discontinuance entry for an imaging device, which is a maker's choice, not a shortage. **Last read:** updated 16 June 2026; six product codes listed, none imaging; two ultrasound discontinuances only. **Leans toward:** neither; an empty list fits both ends while helium is allocated rather than absent.

CM1 and CM3 are live in the command centre today. CM2 and CM4 need a person each quarter, because EUR-Lex renders poorly to a machine and the shortage list is prose.

## Critical factors

Panel judgement: the buyer never sees U1 or U2 directly, only a proclamation, a tender rule, a cleared device and a shortage notice (N35, N36). A sealed 3 tesla clearance is the reading that would move tender pull fastest.

## Predetermined versus uncertain

Predetermined: CM1 and CM3 exist as feeds and keep publishing. Uncertain: whether a committee ever reads CM4 before writing "unreliable" is a causation uncertainty on N36; whether CM2 is widened is an outcomes uncertainty.

## Contradictions with other lenses

None yet; round 1. This lens expects Foreign trade to prefer the truce notice over CM2; a European committee's choice of measure would settle it.

## Blind spots of this lens

This lens misses factory readings (cover days at N19, the test draw). CM3 counts clearances, not installs; a cleared sealed magnet nobody buys reads falsely as end B.

## Sources

Federal Register API, presidential documents search, read 11 Oct 2026, primary: address in CM1.

EUR-Lex, Regulation (EU) 2025/1197, 20 June 2025, primary, carried from phase 2: address in CM2.

openFDA, device 510(k) endpoint, product code LNH, read 11 Oct 2026, primary: address in CM3.

FDA, medical device shortages list, updated 16 June 2026, primary: address in CM4.
